-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18

Benzinga·03/05/2026 17:45:54
Listen to the news
B. Riley Securities analyst Neil Chatterji maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and lowers the price target from $28 to $18.